Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment

Tejas P Joshi; Madeleine Duvic

doi:10.1016/j.jaad.2023.01.047

Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment

J Am Acad Dermatol. 2023 Jun;88(6):e305-e306. doi: 10.1016/j.jaad.2023.01.047. Epub 2023 Feb 28.

Authors

Tejas P Joshi¹, Madeleine Duvic²

Affiliations

¹ School of Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: tejas.joshi@bcm.edu.
² Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas.

PMID: 36858155
DOI: 10.1016/j.jaad.2023.01.047

No abstract available

Keywords: Sézary syndrome; atopic dermatitis; cutaneous T-cell lymphoma; dupilumab; folliculotropic mycosis fungoides; hypopigmented mycosis fungoides; mycosis fungoides; psoriasiform mycosis fungoides.

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Mycosis Fungoides* / diagnosis
Mycosis Fungoides* / drug therapy
Sezary Syndrome*
Skin Neoplasms* / diagnosis
Skin Neoplasms* / drug therapy

Substances

dupilumab
Antibodies, Monoclonal, Humanized